Cleared Special

K200733 - Opticross 35 15 MHz Peripheral Imaging Catheter (FDA 510(k) Clearance)

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K200733 · Boston Scientific Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2020
Decision
28d
Days
Class 2
Risk

K200733 is an FDA 510(k) clearance for the Opticross 35 15 MHz Peripheral Imaging Catheter. Classified as Transducer, Ultrasonic, Diagnostic (product code ITX), Class II - Special Controls.

Submitted by Boston Scientific Corporation (Maple Grove, US). The FDA issued a Cleared decision on April 17, 2020 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 892.1570 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Boston Scientific Corporation devices

Submission Details

510(k) Number K200733 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 20, 2020
Decision Date April 17, 2020
Days to Decision 28 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 125d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code ITX Transducer, Ultrasonic, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - ITX Transducer, Ultrasonic, Diagnostic

All 408
Devices cleared under the same product code (ITX) and FDA review panel - the closest regulatory comparables to K200733.
ULTRASONIC PROBE UM-3R (UM-3R)
K250883 · Olympus Medical Systems Corporation · Sep 2025
ULTRASONIC PROBE UM-S20-17S (UM-S20-17S)
K250762 · Olympus Medical Systems Corporation · Jul 2025
Mendaera Guidance System
K250524 · Mendaera, Inc. · Jul 2025
Accuro® 3S Needle Guide Kit
K250469 · Rivanna Medical, Inc. · Jun 2025
Ultrasound Transducer Cover
K241662 · Vitrolife Sweden AB · Aug 2024
UltraDrape UGPIV Barrier and Securement (34-15)
K233965 · Parker Laboratories, Inc. · Aug 2024